NanoenTekInc Total Liabilities
NanoenTekInc total liabilities. Based on the latest financial reports, NanoenTekInc (039860) has total liabilities worth ₩5.42 Billion KRW (≈ $3.68 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check NanoenTekInc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of NanoenTekInc (2007–2024)
Total liabilities of NanoenTekInc from 2007 to 2024. This chart illustrates how NanoenTekInc's total liabilities have evolved over time, based on quarterly financial data. Explore 039860 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
NanoenTekInc Competitors by Total Liabilities
The table below lists competitors of NanoenTekInc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
UBcare. Co. Ltd
KQ:032620
|
Korea | ₩73.17 Billion |
|
Mobase Electronics Co.Ltd
KQ:012860
|
Korea | ₩528.44 Billion |
|
5E Advanced Materials Inc
NASDAQ:FEAM
|
USA | $3.89 Million |
|
Enterprise Group Inc
TO:E
|
Canada | CA$39.38 Million |
|
Hana Pharm Co Ltd
KO:293480
|
Korea | ₩114.94 Billion |
|
Source Energy Services Ltd
TO:SHLE
|
Canada | CA$387.55 Million |
|
Insight Molecular Diagnostics Inc.
NASDAQ:IMDX
|
USA | $50.74 Million |
|
Patagonia Gold Corp
V:PGDC
|
Canada | CA$74.97 Million |
Liability Composition Analysis (2007–2024)
This chart breaks down NanoenTekInc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 039860 current and non-current assets.
Liquidity & Leverage Metrics
NanoenTekInc Total Liabilities Ratios Explained
NanoenTekInc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 13.31 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.07 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.07 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how NanoenTekInc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for NanoenTekInc (2007–2024)
The table below shows the annual total liabilities of NanoenTekInc from 2007 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩5.01 Billion ≈ $3.40 Million |
+0.54% |
| 2023-12-31 | ₩4.99 Billion ≈ $3.38 Million |
-11.42% |
| 2022-12-31 | ₩5.63 Billion ≈ $3.81 Million |
-44.35% |
| 2021-12-31 | ₩10.11 Billion ≈ $6.85 Million |
+38.01% |
| 2020-12-31 | ₩7.33 Billion ≈ $4.97 Million |
+30.55% |
| 2019-12-31 | ₩5.61 Billion ≈ $3.80 Million |
-19.93% |
| 2018-12-31 | ₩7.01 Billion ≈ $4.75 Million |
-62.38% |
| 2017-12-31 | ₩18.64 Billion ≈ $12.63 Million |
-7.41% |
| 2016-12-31 | ₩20.13 Billion ≈ $13.64 Million |
+40.99% |
| 2015-12-31 | ₩14.28 Billion ≈ $9.68 Million |
+84.03% |
| 2014-12-31 | ₩7.76 Billion ≈ $5.26 Million |
-63.45% |
| 2013-12-31 | ₩21.23 Billion ≈ $14.38 Million |
-1.09% |
| 2012-12-31 | ₩21.46 Billion ≈ $14.54 Million |
+2.68% |
| 2011-12-31 | ₩20.90 Billion ≈ $14.16 Million |
+193.93% |
| 2007-12-31 | ₩7.11 Billion ≈ $4.82 Million |
-- |
About NanoenTekInc
NanoEntek, Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, a resid… Read more